Alternative Dosing of Exemestane in Postmenopausal Women With Stage 0-II ER-Positive Breast Cancer: A Randomized Presurgical Trial
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Exemestane (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Dec 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Jan 2019.
- 21 Dec 2016 Status changed from not yet recruiting to recruiting.